JP2018527330A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018527330A5 JP2018527330A5 JP2018504650A JP2018504650A JP2018527330A5 JP 2018527330 A5 JP2018527330 A5 JP 2018527330A5 JP 2018504650 A JP2018504650 A JP 2018504650A JP 2018504650 A JP2018504650 A JP 2018504650A JP 2018527330 A5 JP2018527330 A5 JP 2018527330A5
- Authority
- JP
- Japan
- Prior art keywords
- fibrosis
- inhibitor
- optionally substituted
- alkyl
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 CC(C)C(C(I)[U]1)=C(*)C1=O Chemical compound CC(C)C(C(I)[U]1)=C(*)C1=O 0.000 description 3
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020127888A JP7457360B2 (ja) | 2015-07-30 | 2020-07-29 | 線維症の処置 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015903035 | 2015-07-30 | ||
| AU2015903035A AU2015903035A0 (en) | 2015-07-30 | Fibrotic treatment | |
| PCT/AU2016/050681 WO2017015720A1 (en) | 2015-07-30 | 2016-07-29 | Fibrotic treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020127888A Division JP7457360B2 (ja) | 2015-07-30 | 2020-07-29 | 線維症の処置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018527330A JP2018527330A (ja) | 2018-09-20 |
| JP2018527330A5 true JP2018527330A5 (https=) | 2019-03-07 |
Family
ID=57883919
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018504650A Withdrawn JP2018527330A (ja) | 2015-07-30 | 2016-07-29 | 線維症の処置 |
| JP2020127888A Active JP7457360B2 (ja) | 2015-07-30 | 2020-07-29 | 線維症の処置 |
| JP2022199857A Pending JP2023030022A (ja) | 2015-07-30 | 2022-12-15 | 線維症の処置 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020127888A Active JP7457360B2 (ja) | 2015-07-30 | 2020-07-29 | 線維症の処置 |
| JP2022199857A Pending JP2023030022A (ja) | 2015-07-30 | 2022-12-15 | 線維症の処置 |
Country Status (8)
| Country | Link |
|---|---|
| US (5) | US10100311B2 (https=) |
| EP (1) | EP3328384B1 (https=) |
| JP (3) | JP2018527330A (https=) |
| AU (1) | AU2016301113B2 (https=) |
| CA (1) | CA3017028C (https=) |
| HK (1) | HK1256423A1 (https=) |
| SG (1) | SG11201808478RA (https=) |
| WO (1) | WO2017015720A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016259977A1 (en) * | 2015-05-08 | 2017-11-23 | Monash University | 4H-pyran compounds as insulin-regulated aminopeptidase (IRAP) inhibitors |
| CA3017028C (en) | 2015-07-30 | 2020-06-16 | Monash University | Fibrotic treatment |
| AU2018303333B2 (en) * | 2017-07-17 | 2023-02-09 | Monash University | Angiotensin receptor agonists and uses thereof |
| JP2022516611A (ja) * | 2018-12-28 | 2022-03-01 | ザ ジェネラル ホスピタル コーポレイション | 線維性疾患の治療のための抗エフリン－ｂ２遮断抗体 |
| WO2021050089A1 (en) * | 2019-09-09 | 2021-03-18 | Washington State University | Genetic test for identifying cats at a high risk for developing tubulointerstitial fibrosis |
| TW202143994A (zh) | 2020-02-19 | 2021-12-01 | 美商希皮恩製藥公司 | 環孢素類似物於治療纖維化之用途 |
| EP4440570A1 (en) * | 2021-12-01 | 2024-10-09 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Irap inhibitors for use in the treatment of inflammatory diseases |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ553688A (en) * | 2004-09-09 | 2011-05-27 | Florey Howard Inst | Enzyme inhibitors for the inhibition of insulin-regulated aminopeptidase |
| CN101247819A (zh) * | 2005-08-23 | 2008-08-20 | 惠氏公司 | 治疗焦虑症和鉴定抗焦虑剂的方法 |
| WO2009065169A1 (en) * | 2007-11-19 | 2009-05-28 | Howard Florey Institute | Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof |
| KR20150028761A (ko) | 2011-12-16 | 2015-03-16 | 타릭스 파마슈티컬스 엘티디. | 섬유증 치료용 안지오텐신 |
| JP2015509483A (ja) * | 2012-02-06 | 2015-03-30 | グラクソスミスクライン、インテレクチュアル、プロパティー、ナンバー２、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｎｏ．２ Ｌｉｍｉｔｅｄ | 線維症を治療するためのｐｉ３ｋ阻害剤 |
| JP6327923B2 (ja) | 2014-04-25 | 2018-05-23 | 旭化成株式会社 | ポリアセタール樹脂組成物、及びそれからなる成形体 |
| DE102014114090A1 (de) | 2014-09-29 | 2016-03-31 | Karlsruher Institut für Technologie | Verfahren zur Abtrennung von Aluminium bei der Calciumsilikatproduktion |
| US9519061B2 (en) * | 2014-12-26 | 2016-12-13 | Here Global B.V. | Geometric fingerprinting for localization of a device |
| AU2016259977A1 (en) * | 2015-05-08 | 2017-11-23 | Monash University | 4H-pyran compounds as insulin-regulated aminopeptidase (IRAP) inhibitors |
| CA3017028C (en) * | 2015-07-30 | 2020-06-16 | Monash University | Fibrotic treatment |
-
2016
- 2016-07-29 CA CA3017028A patent/CA3017028C/en active Active
- 2016-07-29 AU AU2016301113A patent/AU2016301113B2/en active Active
- 2016-07-29 WO PCT/AU2016/050681 patent/WO2017015720A1/en not_active Ceased
- 2016-07-29 EP EP16829507.9A patent/EP3328384B1/en active Active
- 2016-07-29 JP JP2018504650A patent/JP2018527330A/ja not_active Withdrawn
- 2016-07-29 SG SG11201808478RA patent/SG11201808478RA/en unknown
- 2016-07-29 US US15/747,697 patent/US10100311B2/en active Active
- 2016-07-29 HK HK18115556.4A patent/HK1256423A1/zh unknown
-
2018
- 2018-09-06 US US16/123,898 patent/US10787668B2/en active Active
-
2020
- 2020-07-29 JP JP2020127888A patent/JP7457360B2/ja active Active
- 2020-08-04 US US16/984,996 patent/US11078488B2/en active Active
-
2021
- 2021-07-01 US US17/365,260 patent/US11834663B2/en active Active
-
2022
- 2022-12-15 JP JP2022199857A patent/JP2023030022A/ja active Pending
-
2023
- 2023-10-26 US US18/495,512 patent/US20240084308A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018527330A5 (https=) | ||
| JP2020189845A5 (https=) | ||
| JP6526306B2 (ja) | バルドキソロンメチルまたはその類似体を使用して内皮機能障害を処置および予防する方法 | |
| Leask et al. | Back to the future: targeting the extracellular matrix to treat systemic sclerosis | |
| US20240084308A1 (en) | Fibrotic treatment | |
| BR122018015003B1 (pt) | kit compreendendo composições farmacêuticas de inibidor da nep e de valsartan ou seus sais | |
| JPWO2005095327A1 (ja) | アニリン誘導体 | |
| WO2012143377A1 (en) | Niclosamide for the treatment of cancer metastasis | |
| JP2023030022A5 (https=) | ||
| KR20170141757A (ko) | 테트라하이드로나프티리디닐 프로피온산 유도체 및 이의 용도 | |
| PT1259242E (pt) | Utilização de inibidores de tirosina quinase de receptores de pdgf para o tratamento da nefropatia diabética | |
| JP2002544178A (ja) | 腎機能障害の治療用の医薬の製造のためのドーパミン−ｄ３−レセプターリガンドの使用 | |
| KR20220098757A (ko) | Bet 브로모도메인 억제제 및 나트륨 의존 글루코스 수송 2 억제제와 병용하여 주요 부정적 심혈관 사건 (mace)을 치료 및/또는 예방하는 방법 | |
| JP7755919B2 (ja) | 糖尿病性腎症の予防薬及び／又は治療薬 | |
| US11766423B2 (en) | 2,6-dimethoxy-4-(5-phenyl-4-thiophene-2-yl-1H-imidazol-2-yl)-phenol (DPTIP) a small molecule inhibitor of neutral sphingomyelinase 2 (nSMase-2) for the treatment of neurodegenerative and oncologic diseases | |
| JP2005501015A (ja) | アルツハイマー病を治療する方法 | |
| TW201215389A (en) | Sustained-release therapeutic agent for hypertension and renal dysfunction | |
| JP2008512395A5 (https=) | ||
| JP2025511786A (ja) | 筋線維症の治療 | |
| US20210260153A1 (en) | Use of cyclosporine analogues for treating fibrosis | |
| KR20240007258A (ko) | 리실 옥시다제의 억제제로서 비티아졸 유도체 | |
| JPWO2004093858A1 (ja) | Ｍｍｐ発現抑制剤 | |
| KR20220140268A (ko) | 신규한 인돌라진 유도체 및 이를 포함하는 섬유증의 예방 또는 치료용 조성물 | |
| Arts et al. | Histone Deacetylase Inhibitors: From Chromatin Remodelling to Experimental Cancer Therapeutics | |
| JP2002326957A (ja) | 慢性閉塞性肺疾患の治療方法 |